Advertisement
Advertisement
U.S. Markets open in 3 hrs 49 mins
S&P Futures
3,902.00 +4.25 (+0.11%) Dow Futures
31,241.00 +39.00 (+0.12%) Nasdaq Futures
11,838.00 -40.25 (-0.34%) Russell 2000 Futures
1,771.50 -3.40 (-0.19%) Crude Oil
110.35 +0.46 (+0.42%) Gold
1,845.10 +3.90 (+0.21%)
Boyd Gaming Corporation (BYD)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 54.50 |
| Open | 55.32 |
| Bid | 52.99 x 1000 |
| Ask | 56.75 x 800 |
| Day's Range | 53.31 - 55.58 |
| 52 Week Range | 50.38 - 72.72 |
| Volume | |
| Avg. Volume | 1,162,863 |
| Market Cap | 6.18B |
| Beta (5Y Monthly) | 1.97 |
| PE Ratio (TTM) | 14.36 |
| EPS (TTM) | 3.83 |
| Earnings Date | Apr 25, 2022 - Apr 29, 2022 |
| Forward Dividend & Yield | 0.60 (1.06%) |
| Ex-Dividend Date | Mar 14, 2022 |
| 1y Target Est | 79.64 |
- Simply Wall St.
Is Now The Time To Put Boyd Gaming (NYSE:BYD) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
- GlobeNewswire
Cassava Sciences Reports First Quarter Financial Results for 2022 and Updates on Phase 3 Clinical Program
- $209.7 Million Cash and Cash Equivalents at March 31, 2022 – - Over 120 Patients Now Enrolled in Phase 3 Program - AUSTIN, Texas, May 05, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for the first quarter ended March 31, 2022 and provided a clinical update on its Phase 3 clinical program of simufilam in Alzheimer’s disease. Simufilam is Cassava Sciences’ lead drug candida
- Simply Wall St.
When Should You Buy Boyd Gaming Corporation (NYSE:BYD)?
Boyd Gaming Corporation ( NYSE:BYD ), is not the largest company out there, but it received a lot of attention from a...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
